Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,259,000 | 2,338,000 | 22,072,000 | 19,498,000 | 16,899,000 |
| Depreciation Amortization | 2,880,000 | 1,456,000 | 6,410,000 | 4,921,000 | 3,400,000 |
| Income taxes - deferred | 851,000 | 345,000 | 1,703,000 | 1,644,000 | 1,235,000 |
| Accounts receivable | N/A | N/A | 940,000 | N/A | N/A |
| Other Working Capital | -1,949,000 | -1,091,000 | -3,378,000 | -4,749,000 | -5,464,000 |
| Other Operating Activity | -19,000 | -113,000 | -10,063,000 | -9,354,000 | -10,010,000 |
| Operating Cash Flow | $7,022,000 | $2,935,000 | $17,684,000 | $11,960,000 | $6,060,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,113,000 | 348,000 | -5,911,000 | -7,096,000 | -7,562,000 |
| PPE Investments | -570,000 | -292,000 | -1,206,000 | -789,000 | -511,000 |
| Net Acquisitions | N/A | N/A | -15,000 | -15,000 | -15,000 |
| Purchase Of Investment | -5,327,000 | -1,808,000 | -11,020,000 | -8,746,000 | -5,233,000 |
| Sale Of Investment | 2,947,000 | 1,454,000 | 7,555,000 | 5,943,000 | 3,194,000 |
| Purchase Sale Intangibles | -56,000 | -6,000 | -259,000 | -177,000 | -127,000 |
| Other Investing Activity | 232,000 | 200,000 | 53,000 | 17,000 | 44,000 |
| Investing Cash Flow | $-1,605,000 | $-98,000 | $-10,544,000 | $-10,686,000 | $-10,083,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -2,691,000 | 1,031,000 | 7,798,000 | 5,554,000 | 4,585,000 |
| Debt Issued | 4,491,000 | N/A | 6,618,000 | 6,618,000 | 6,618,000 |
| Debt Repayment | -752,000 | -752,000 | -4,146,000 | -2,396,000 | -2,394,000 |
| Common Stock Issued | 583,000 | 425,000 | 1,750,000 | 1,370,000 | 1,175,000 |
| Common Stock Repurchased | -2,520,000 | -1,197,000 | -16,290,000 | -11,643,000 | -7,889,000 |
| Dividend Paid | -3,320,000 | -1,662,000 | -6,580,000 | -5,026,000 | -3,436,000 |
| Other Financing Activity | 36,000 | 22,000 | -4,125,000 | -3,708,000 | -2,259,000 |
| Financing Cash Flow | $-4,173,000 | $-2,133,000 | $-14,975,000 | $-9,231,000 | $-3,600,000 |
| Exchange Rate Effect | -21,000 | -25,000 | -63,000 | -72,000 | -22,000 |
| Beginning Cash Position | 2,183,000 | 2,183,000 | 10,081,000 | 10,081,000 | 10,081,000 |
| End Cash Position | 3,406,000 | 2,862,000 | 2,183,000 | 2,052,000 | 2,436,000 |
| Net Cash Flow | $1,223,000 | $679,000 | $-7,898,000 | $-8,029,000 | $-7,645,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,022,000 | 2,935,000 | 17,684,000 | 11,960,000 | 6,060,000 |
| Capital Expenditure | -570,000 | -292,000 | -1,206,000 | -789,000 | -511,000 |
| Free Cash Flow | 6,452,000 | 2,643,000 | 16,478,000 | 11,171,000 | 5,549,000 |